Literature DB >> 30792187

Frequent germline mutations of HAVCR2 in sporadic subcutaneous panniculitis-like T-cell lymphoma.

Chantana Polprasert1,2, Yasuhide Takeuchi3,4, Nobuyuki Kakiuchi3, Kenichi Yoshida3, Thamathorn Assanasen5, Wimonmas Sitthi5, Udomsak Bunworasate1,2, Arunrat Pirunsarn6, Kitsada Wudhikarn1,2, Panisinee Lawasut1,2, Noppacharn Uaprasert1, Sunisa Kongkiatkamon1,2, Chatphatai Moonla1, Masashi Sanada7, Nobuhiro Akita8, June Takeda3, Yoichi Fujii3, Hiromichi Suzuki3, Yasuhito Nannya3, Yuichi Shiraishi9, Kenichi Chiba9, Hiroko Tanaka9, Satoru Miyano9, Ponlapat Rojnuckarin1,2, Seishi Ogawa3, Hideki Makishima3.   

Abstract

Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a rare subtype of peripheral T-cell lymphoma affecting younger patients and associated with hemophagocytic lymphohistiocytosis. To clarify the molecular pathogenesis of SPTCL, we analyzed paired tumor and germline DNAs from 13 patients by whole-exome sequencing. All cases were Asians and were phenotypically sporadic with no family history of SPTCL. Consistent with a recent report, germline mutations in HAVCR2, encoding T-cell immunoglobulin mucin 3 (TIM3), were identified in 11 of 13 (85%) cases. All mutated cases were primary SPTCL, whereas the 2 cases without mutation were secondary SPTCL associated with underlying diseases, including viral infection and autoimmune disease. Ten patients harbored homozygous p.Y82C mutations, and 1 showed compound heterozygous mutations (p.Y82C and p.T101I). Both missense mutations altered highly conserved residues located in the extracellular immunoglobulin variable-like domain. According to the Genome Aggregation Database of >138 500 general individuals, both mutations were documented with minor allele frequencies < 0.007, indicating remarkable enrichment of these HAVCR2 alleles in SPTCL. SPTCL cells also harbored somatic mutations (6.2 per patient) that are frequently identified in genes associated with epigenetic regulation and signal transduction. In conclusion, individuals harboring biallelic HAVCR2 (TIM3) germline mutations were highly susceptible to sporadic SPTCL, which was also associated with clonal somatic mutations.
© 2019 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30792187      PMCID: PMC6391671          DOI: 10.1182/bloodadvances.2018028340

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  13 in total

1.  Efficacy of ruxolitinib in subcutaneous panniculitis-like T-cell lymphoma and hemophagocytic lymphohistiocytosis.

Authors:  Romain Lévy; Mathieu Fusaro; Frédéric Guerin; Ahmed Chetouani; Despina Moshous; Alain Fischer; Geneviève de Saint Basile; Fernando E Sepulveda; Bénédicte Neven
Journal:  Blood Adv       Date:  2020-04-14

Review 2.  CEACAM1 structure and function in immunity and its therapeutic implications.

Authors:  Walter M Kim; Yu-Hwa Huang; Amit Gandhi; Richard S Blumberg
Journal:  Semin Immunol       Date:  2019-04       Impact factor: 11.130

Review 3.  Maximizing insights from monogenic immune disorders.

Authors:  Anis Barmada; Anjali Ramaswamy; Carrie L Lucas
Journal:  Curr Opin Immunol       Date:  2021-10-22       Impact factor: 7.486

Review 4.  Molecular understanding of peripheral T-cell lymphomas, not otherwise specified (PTCL, NOS): A complex disease category.

Authors:  Mamiko Sakata-Yanagimoto; Kota Fukumoto; Kennosuke Karube; Shigeru Chiba
Journal:  J Clin Exp Hematop       Date:  2021-03-15

Review 5.  Tim-3 finds its place in the cancer immunotherapy landscape.

Authors:  Nandini Acharya; Catherine Sabatos-Peyton; Ana Carrizosa Anderson
Journal:  J Immunother Cancer       Date:  2020-06       Impact factor: 13.751

6.  TIM-3 drives temporal differences in restimulation-induced cell death sensitivity in effector CD8+ T cells in conjunction with CEACAM1.

Authors:  Camille M Lake; Kelsey Voss; Bradly M Bauman; Katherine Pohida; Timothy Jiang; Gabriela Dveksler; Andrew L Snow
Journal:  Cell Death Dis       Date:  2021-04-14       Impact factor: 8.469

7.  Single-Cell RNA-seq Reveals Characteristics of Malignant Cells and Immune Microenvironment in Subcutaneous Panniculitis-Like T-Cell Lymphoma.

Authors:  Zifeng Li; Hongsheng Wang; Rui Dong; Jie Man; Li Sun; Xiaowen Qian; Xiaohua Zhu; Ping Cao; Yi Yu; Jun Le; Yang Fu; Ping Wang; Wenjin Jiang; Chen Shen; Yangyang Ma; Lian Chen; Yaochen Xu; Jiantao Shi; Hui Zhang; Maoxiang Qian; Xiaowen Zhai
Journal:  Front Oncol       Date:  2021-03-18       Impact factor: 6.244

8.  TIM-3 restrains anti-tumour immunity by regulating inflammasome activation.

Authors:  Karen O Dixon; Marcin Tabaka; Markus A Schramm; Sheng Xiao; Ruihan Tang; Danielle Dionne; Ana C Anderson; Orit Rozenblatt-Rosen; Aviv Regev; Vijay K Kuchroo
Journal:  Nature       Date:  2021-06-09       Impact factor: 49.962

9.  Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee.

Authors:  Stuart G Tangye; Waleed Al-Herz; Aziz Bousfiha; Talal Chatila; Charlotte Cunningham-Rundles; Amos Etzioni; Jose Luis Franco; Steven M Holland; Christoph Klein; Tomohiro Morio; Hans D Ochs; Eric Oksenhendler; Capucine Picard; Jennifer Puck; Troy R Torgerson; Jean-Laurent Casanova; Kathleen E Sullivan
Journal:  J Clin Immunol       Date:  2020-01-17       Impact factor: 8.317

Review 10.  [PD-1 monoclonal antibody combined with chemotherapy in the treatment of subcutaneous panniculitis-like T-cell lymphoma: a case report and literature review].

Authors:  S Qu; L S Liao; Y Xie; Z H Zheng; B Y Chen
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2021-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.